The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
The Executive Committee both manages and represents ERS by directing and conducting the general activities of the Society on behalf of the General Assembly. The Executive Committee provides an annual report on all activities to the General Assembly.
None
None
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
| Company | Area | Product | Amount of funds received* |
|---|---|---|---|
| Acceleron | Pulmonary Hypertension | Sotatercept | B |
| Janssen | Pulmonary Hypertension | Epoprostenol, Macitentan, Selexipag | B |
| Bayer | Pulmonary Hypertension | Riociguat | B |
| Astrazeneca | Asthma | Benralizumab | A |
| GSK | Asthma | Mepolizumab | B |
| Sanofi | Asthma | Dupilumab | B |
| MorphogenIX | Pulmonary Hypertension | BMP9 | B |
| Novartis | Asthma | Omalizumab | B |
| AOP Orphan | Pulmonary Hypertension | Treprostinil | C |
| MSD | Pulmonary Hypertension | Riociguat, Sotatercept | C |
| Chiesi | Asthma, Pulmonary Hypertension | None | C |
None
None
None
| Company | Nature of Support | Amount of funds received* |
|---|---|---|
| MSD | Research lab support | D |
| Shou Ți | Research lab support | C |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
| Company | Area | Product | Amount of funds received* |
|---|---|---|---|
| PMD | Respiratory Device | Respirasense | B |
| Centric Health | Respiratory digial health | CareConnect | B |
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| GSK | Lectures | A |
| AstraZeneca | Lectures | A |
| BioNTech | Lectures | A |
None
None
| Company | Nature of Support | Amount of funds received* |
|---|---|---|
| GSK | Grant to Institute for research | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
| Company | Area | Product | Amount of funds received* |
|---|---|---|---|
| Astra Zeneca | Advisory Board/Invited speaker | presentation | A |
| GSK | Advisory Board/Invited Speaker | presentation | A |
| Novartis | Invited speaker | presentation | A |
| Abdi İbrahim | Advisory Board/Invited speaker | presentation | A |
| DEVA | Advisory Board/Invited speaker | presentation | A |
| BİLİM | Advisory Board/Invited speaker | presentation | A |
| CHIESI | Advisory Board/Invited speaker | presentation | A |
None
| Company | Purpose and Nature of Benefit | Amount of funds received* |
|---|---|---|
| ERS | Support to travel to meetings | A |
| GINA | Support to travel to meetings | A |
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
Kjeld Hansen is the Chair of the European Lung Foundation (ELF) and has been associated with ELF since 2012. In his professional capacity, Kjeld is working with digitalisation and is employed by the academic institution Kristiania in Oslo, Norway.
In his patient advocacy work, Kjeld is inspired by digitalisation as an enabler for new approaches and organisational forms that put people with respiratory conditions at the centre of the initiative.
None
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| Art Tempi Communications | Compensation of time for contributions to "Patients Today" | A |
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| Chiesi | Lectures | B |
| GSK | Lectures | B |
| Sanofi | Lectures | B |
| Boehringer | Lectures | A |
None
None
| Company | Nature of Support | Amount of funds received* |
|---|---|---|
| Air Liquide | Research project | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
All ERS Assembly Heads are also members of the Executive Committee.
